| Name: | Cefixime EP Impurity D |
| Catalogue No. | VE007703 |
| CAS No. | 97164-56-2 |
| Molecular Formula | C16H15N5O7S2 |
| Molecular Weight | 453.45 g/mol |
| Status | In-Stock |
| IUPAC Name | (6R,7R)-7-[[(E)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl] amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| Synonyms | Cefixime E-Isomer |
| Description | Cefixime EP Impurity D (CAS No: 97164-56-2) Or (6R,7R)-7-[[(E)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl] amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefixime is an active beta-lactam antibiotic,which is used for the treatment of bacterial disorders such as the ear, throat, lung, and urinary tract infections, bronchitis,gonorrhea, and pneumonia. |
| References | Sci-Hub | Bactericidal potentials of silver and gold nanoparticles stabilized with cefixime: a strategy against antibiotic-resistant bacteria | 10.1007/s11051-020-04939-y. (2020). Retrieved January 11, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1007/s11051-020-04939-y |
